导师姓名： 虞永峰 专业代码： 100214
性别： 男 专业名称： 肿瘤学
培养单位： 附属胸科医院 三级学科/
专业领域：
导师类型： 硕士生导师 专业学位导师： 兼
联系方式：
邮编： 邮箱地址： yuyongfeng212@sina.com

研究方向 (点击浏览详细信息)
肺癌驱动基因研究和肺癌多学科综合治疗

社会任职
上海市抗癌协会胸部肿瘤委员会青年委员
中国医药教育协会肿瘤免疫治疗专业委员会秘书长
CSCO青年委员
中国抗癌协会肺癌专业委员会青委会副主任委员
《Journal of Thoracic Disease》(SCI收录) 特邀审稿人
国际肺癌研究协会（IASLC）会员（会员号：414443）
《解放军医学杂志》特邀审稿人
中国抗癌协会（CSCO）会员（会员号：**）

科研项目 项目编号项目名称课题来源起止年月批准经费承担职责
** c-Met激酶选择性抑制剂SPH3348的临床前开发 上海市科委“科技创新行动计划”生物医药领域科技支撑项目 2016-07~2019-09 15万元 子课题负责人
** 基于活性的蛋白质谱分析在早期非小细胞肺癌分子分型中的运用 国家自然科学基金青年项目 2013-01~2015-12 23万元 课题负责人

学术论文 作者论文标题期刊名出版年卷期页码
Yongfeng Yu, Qiuxiang Ou,Xue Wu,Hairong Bao,Yan Ding,Yang W. Shao,Shun Lu Concomitant resistance mechanisms to multiple tyrosine kinase inhibitors in ALK-positive non-small cell lung cancer Lung Cancer 2019 127(1):19-24.
Shun Lu,Yongfeng Yu （共同第一作者）,Ziming Li,Ruoying Yu,Xue Wu,Hairong Bao,Yan Ding, Yang W. Shao,Hong Jian EGFR and ERBB2 Germline Mutations in Chinese Lung Cancer Patients and Their Roles in Genetic Susceptibility to Cancer J Thorac Oncol 2019 14(4):732-736
Rongrong Chen, Xiaohua Yang,Zhengping Ding,Lei Zhu,Shun Lu,Yongfeng Yu （通讯作者） Lung squamous cell carcinoma: A postoperative recurrence analysis of keratinizing and nonkeratinizing subtypes Eur J Surg Oncol 2019 45(5):838-844
Rongrong Chen, Zhengping Ding, Lei Zhu, Shun Lu, Yongfeng Yu （通讯作者） Correlation of Clinicopathologic Features and Lung Squamous Cell Carcinoma Subtypes According to the 2015 WHO Classification Eur J Surg Oncol 2017 43(12):2308-2314.
Yu Y, Jian H, Shen L, Zhu L, Lu S Lymph node involvement influenced by lung adenocarcinoma subtypes in tumor size ≤3 cm disease: A study of 2268 cases Eur J Surg Oncol 2016 2016,42(11):1714-1719
Yu Y1, Ding Z, Jian H, Shen L, Zhu L, Lu S Prognostic value of MMP9 activity level in resected stage I B lung adenocarcinoma. Cancer Med 2016 2016,5(9):2323-2331
Yongfeng Yu, Zhengping Ding, Lei Zhu, Haohua Teng, Shun Lu Frequencies of ALK Rearrangements in Lung Adenocarcinoma Subtypes: a Study of 2299 Chinese Cases SpringerPlus 2016 2016,5: 894
Yongfeng Yu,Zhengbo Song,Shunfang Yang, et al. Everolimus and zoledronic acid-a potential synergistic treatment for lung adenocarcinoma bone metastasis Acta Biochim Biophys Sin 2014 2014,46(9):792-801
Yongfeng Yu, Zhengbo Song, et al. EGFR L861Q mutation is a frequent feature of pulmonary mucoepidermoid carcinoma Journal of Cancer Research and Clinical Oncology 2012 2012,138(8):1421-1425
Yongfeng Yu, Zhengbo Song, Shun Lu ,et al. Chinese Pediatric and Adolescent Primary Tracheobronchial Tumors:a Hospital- Based Study Pediatric Surgery International 2011 2011,27(7):721-726
Zhengbo Song, Yongfeng Yu （共同第一作者）, Shun Lu ,et al. Third-Line Therapy for Advanced Non-Small-Cell Lung Cancer Patients: Feasible Drugs for Feasible Patients Medical Oncology 2011 2011,28,S605-S612
Yong-feng Yu, Zhi-wei Chen, Zhen Zhou, Shun Lu.,et al. A Cost-Effectiveness Analysis of Docetaxel versus Pemetrexedin Second-line Chemotherapy for Stage III b or IV Non-Small Cell Lung Cancer Patients in China. CHEMOTHERAPY 2010 2010,56(6):472-477
Zhiwei Chen, Yongfeng Yu （共同第一作者）, Shun Lu,et al. Functional roles of PC-PLC and Cdc20 in the cell cycle, proliferation, and apoptosis Cell Biochem Funct 2010 2010,28(4):249-57
Yongfeng Yu,ZiMing Li,Shun Lu,et al. The Effect of Cetuxmab Alone and in Combination With Endostatin on Vascular Endothelial Growth Factor and Interleukin-8 Expression in Human Lung Adenocarcinoma Cells Current Therapeutic Research 2009 2009,70(2):116-128